7.24.2023 - Sharpening the SABR

Check out this week's QuadCast as we highlight the benefit of immunotherapy with SABR for NSCLC, the refreshing Common Sense Oncology Initiative, the interaction of corticosteroids and immunotherapy, and more. quadshotnews.com